ArticleCarcinogenesis2016

Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinoma.

Kevin D McCormick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.